Back to the search results

Universitätsmedizin Rostock - Teilkörperschaft der Universität Rostock

Schillingallee 35
18057 Rostock

Phone: 0381-494-0
Fax: 0381-494-5052
Mail: ed.kcotsor-inu.dem@esserp

http://www.med.uni-rostock.de/

Basic information

Number of beds: 788
Number of specialist departments: 27

Number of inpatient cases: 30.397
Number of partial inpatient cases: 2.585
Number of outpatient cases: 272.618

Hospital owners: Universitätsmedizin Rostock - rechtsfähige Teilkörperschaft der Universität Rostock
Type of provider: öffentlich

University Hospital
Academic teaching hospital

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Koronare Herzkrankheit (KHK)

Bei den sog. „Disease-Management-Programmen“ (DMP) handelt es sich um spezielle strukturierte Programme für chronische Krankheiten. Diese zielen darauf, die Versorgung und Betreuung chronisch Erkrankter zu verbessern. Der Universitätsmedizin Rostock ist im Falle chronischer Erkrankungen ein gut abgestimmtes und kontinuierliches Vorgehen bei der gesundheitlichen Versorgung sehr wichtig, um etwa das Risiko für Komplikationen oder Folgeschäden reduzieren oder vermeiden zu können.

Participation in other external comparative quality assurance procedures

Implementation of the minimum quantity agreement

Treatment area

Kidney transplant (including living donation)

Quantity performed	6
Exception?	No exception

Complex operations on the pancreatic organ system

Quantity performed	48
Exception?	No exception

Stem cell transplant

Quantity performed	66
Exception?	No exception

Liver transplantation (including partial liver donation)

Quantity performed	9
Exception?	No exception

Complex interventions on the organ system esophagus for adults

Quantity performed	23
Exception?	No exception

Knee joint total endoprostheses

Quantity performed	132
Exception?	No exception

Minimum quantities forecast

Complex interventions on the organ system esophagus for adults

Overall result forecast presentation:	yes
Quantity performed reporting year:	23
Quantity forecast year:	21
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Liver transplantation (including partial liver donation)

Overall result forecast presentation:	Pending lawsuit
Quantity performed reporting year:	9
Quantity forecast year:	11
Examination by state associations?	no
Exemption?	no
Result of the examination by the federal state authorities?	no
Transitional arrangement?	no

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	132
Quantity forecast year:	162
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Kidney transplantation (including living donation)

Overall result forecast presentation:	yes
Quantity performed reporting year:	6
Quantity forecast year:	14
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Stem cell transplant

Overall result forecast presentation:	yes
Quantity performed reporting year:	66
Quantity forecast year:	71
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Complex operations on the pancreatic organ system

Overall result forecast presentation:	yes
Quantity performed reporting year:	48
Quantity forecast year:	49
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ27	Guideline on quality assurance measures for inpatient care with bronchoscopic lung volume reduction procedures for severe emphysema (QS Guideline bronchoscopic LVR /QS-RL BLVR)
CQ03	Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ02	Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: no

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
326	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
200	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
153	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

Advice on prevention and intervention in cases of violence and abuse

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes
Measures
- Prevention
  Special requirements for the selection of persons
  Note on the measure
  Thema wird regelhaft in Vorstellungsgesprächen und im Rahmen der Mitarbeiter:innengespräche thematisiert, erweiteres Führungszeugnis mandativ
  Information gathering on the topic
  Note on the measure
  im Rahmen der Aufklärung über Aufenthalt Hinweise zu möglichen Beschwerdemöglichkeiten, Hilfewege und Anlaufstellen
  Education
  Note on the measure
  im Rahmen der Information zu Stationsordnung werden Patienten und Eltern sensibilisiert, das Team wird über regelmäßige Fortbildungen sensibilisiert
  Training of employees
  Note on the measure
  regelmäßig mind. 1/Jahr im Rahmen des hausinternenen Kollquiums, zusätzlich gemeinsam mit Kinderschutzgruppe regelmäßge Termine; zusätzlich regelmäßige Arbeitsgruppe zu Minimierung von Zwangsmaßnahmen; regelmäßige (mind.1/Jahr) Schulung in Deeskalationsmanagement
  Age-appropriate complaint options
  Note on the measure
  Briefkasten (anonym), aktives Informieren über Beschwerdemöglichkeiten
  Other aspects of prevention
  Note on the measure
  Kooperation mit Kinderschutzgruppe der UMR und der Kinderschutzgruppe der Hansestadt Rostock
- Intervention
  Intervention plan - Binding procedure for dealing with child protection cases and in particular suspected (sexual) violence
  Note on the measure
  09.03.2022, nächste reguläre Überprüfung 13.12.2023
- Review
  Recommendations for dealing with/processing cases that have occurred
  Note on the measure
  09.03.2022, nächste reguläre Überprüfung 13.12.2023

09.03.2022, nächste reguläre Überprüfung 13.12.2023

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
z.B. Zenzy, SAP, COPRA

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL09 - Doctoral supervision

Explanation

FL05 - Participation in multi-centre Phase I/II studies

Explanation

FL06 - Participation in multi-centre phase III/IV studies

Explanation

FL03 - Student training (clinical traineeship / internship year)

Explanation

in folgenden Studiengängen: Humanmedizin, Zahnmedizin, BA/MA Medizinische Biotechnologie, BA Hebammenwissenschaft, BA Intensivpflege sowie in Kooperation mit anderen Fakultäten der Universität Rostock in den Studiengängen BA/MA Biomedizinische Technik und BA/MA Medizinische Informationstechnik

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

FL04 - Project-related cooperation with colleges and universities

Explanation

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Training

Training in other healing professions

HB10 - Midwife (m/f)

Comment

Seit 2020 dualer BA-Studiengang für Hebammenwissenschaft gem. § 9 ff. Hebammengesetz - HebG.

HB03 - Physical therapist / physiotherapist (m/f)

Comment

Es bestehen Kooperationsverträge mit der Beruflichen Schule "Alexander Schmorell" und Medica-Akademie mit entsprechenden Praktikumsplätzen. Darüber hinaus können Einzelverträge für Praktika abgeschlossen werden. Dies erfolgt auf Anfrage und in Abhängigkeit der Auslastung in den einzelnen Bereichen.

HB19 - Nursing professionals

Comment

Die Ausbildung erfolgt in Kooperation mit der Beruflichen Schule "Alexander Schmorell", dort findet der theoretische Teil der Ausbildung statt . Der praktische Teil der Ausbildung wird in den Einrichtungen der Universitätsmedizin Rostock absolviert. Vertiefung Kinderkrankenpflege ab 2023.

HB15 - Anaesthesia technical assistant (m/f)

Comment

Die Ausbildung der OTA und ATA erfolgt an unserer eigenen Schule für OTA und ATA. Ab dem 01.09.2022 findet die Ausbildung an der Staatlichen Berufsschule an der Universitätsmedizin Rostock statt.

HB07 - Surgical technical assistant (m/f)

Comment

Die Ausbildung der OTA und ATA erfolgt an unserer eigenen Schule für OTA und ATA. Ab dem 01.09.2022 findet die Ausbildung an der Staatlichen Berufsschule an der Universitätsmedizin Rostock statt.

HB02 - Health and paediatric nurse (m/f)

Comment

Die Ausbildung erfolgt in Kooperation mit der Beruflichen Schule "Alexander Schmorell", dort findet der theoretische Teil der Ausbildung statt. Der praktische Teil der Ausbildung wird in den Einrichtungen der Universitätsmedizin Rostock absolviert.

HB01 - Nurse and health care worker (m/f)

Comment

Die Ausbildung erfolgt in Kooperation mit der Beruflichen Schule "Alexander Schmorell", dort findet der theoretische Teil der Ausbildung statt. Der praktische Teil der Ausbildung wird in den Einrichtungen der Universitätsmedizin Rostock absolviert.